Suppr超能文献

侵袭性耳念珠菌感染治疗的药效学优化

Pharmacodynamic Optimization for Treatment of Invasive Candida auris Infection.

作者信息

Lepak Alexander J, Zhao Miao, Berkow Elizabeth L, Lockhart Shawn R, Andes David R

机构信息

Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, USA.

Department of Medical Microbiology and Immunology, University of Wisconsin, Madison, Wisconsin, USA.

出版信息

Antimicrob Agents Chemother. 2017 Jul 25;61(8). doi: 10.1128/AAC.00791-17. Print 2017 Aug.

Abstract

is an emerging multidrug-resistant threat. The pharmacodynamics of three antifungal classes against nine strains was explored using a murine invasive candidiasis model. The total drug median pharmacodynamic (PD) target associated with net stasis was a fluconazole AUC/MIC (the area under the concentration-time curve over 24 h in the steady state divided by the MIC) of 26, an amphotericin B /MIC (maximum concentration of drug in serum divided by the MIC) of 0.9, and a micafungin AUC/MIC of 54. The micafungin PD targets for were ≥20-fold lower than those of other species in this animal model. Clinically relevant micafungin exposures produced the most killing among the three classes.

摘要

是一种新出现的多重耐药威胁。使用小鼠侵袭性念珠菌病模型探索了三类抗真菌药物对九种菌株的药效学。与净停滞相关的总药物中位药效学(PD)靶点为:氟康唑的AUC/MIC(稳态下24小时浓度-时间曲线下面积除以MIC)为26,两性霉素B的Cmax/MIC(血清中药物最大浓度除以MIC)为0.9,米卡芬净的AUC/MIC为54。在该动物模型中,米卡芬净对[具体物种未给出]的PD靶点比其他[具体物种未给出]物种低≥20倍。临床相关的米卡芬净暴露在这三类药物中产生的杀菌效果最佳。

相似文献

1
Pharmacodynamic Optimization for Treatment of Invasive Candida auris Infection.
Antimicrob Agents Chemother. 2017 Jul 25;61(8). doi: 10.1128/AAC.00791-17. Print 2017 Aug.
3
Pharmacokinetic Properties of Micafungin in Critically Ill Patients Diagnosed with Invasive Candidiasis.
Antimicrob Agents Chemother. 2017 Nov 22;61(12). doi: 10.1128/AAC.01398-17. Print 2017 Dec.
6
Recent increase in frequency in the SENTRY surveillance program: antifungal activity and genotypic characterization.
Antimicrob Agents Chemother. 2024 Oct 8;68(10):e0057024. doi: 10.1128/aac.00570-24. Epub 2024 Sep 12.
7
Candida auris and multidrug resistance: Defining the new normal.
Fungal Genet Biol. 2019 Oct;131:103243. doi: 10.1016/j.fgb.2019.103243. Epub 2019 Jun 20.
8
Understanding Echinocandin Resistance in the Emerging Pathogen Candida auris.
Antimicrob Agents Chemother. 2018 May 25;62(6). doi: 10.1128/AAC.00238-18. Print 2018 Jun.
9
Assessment of echinocandin regimens by pharmacokinetic/pharmacodynamic analysis against Candida spp. in paediatric patients.
Int J Antimicrob Agents. 2015 Dec;46(6):631-41. doi: 10.1016/j.ijantimicag.2015.08.009. Epub 2015 Sep 21.
10
Candida Surveillance in Surgical Intensive Care Unit (SICU) in a Tertiary Institution.
BMC Infect Dis. 2015 Jul 3;15:256. doi: 10.1186/s12879-015-0997-6.

引用本文的文献

1
infection at a pediatric burn center: Treatment and infection control measures.
North Clin Istanb. 2025 Jun 11;12(3):285-289. doi: 10.14744/nci.2024.26429. eCollection 2025.
2
: Epidemiology and Antifungal Strategy.
Annu Rev Med. 2025 Jan;76(1):57-67. doi: 10.1146/annurev-med-061523-021233. Epub 2025 Jan 16.
3
Analogs of the anti-malaria drug mefloquine have broad-spectrum antifungal activity and are efficacious in a model of disseminated infection.
Antimicrob Agents Chemother. 2024 Nov 6;68(11):e0130124. doi: 10.1128/aac.01301-24. Epub 2024 Oct 4.
6
Act Now: The Global Threat of Candida Auris and the Urgent Need for Effective Countermeasures.
J Community Hosp Intern Med Perspect. 2024 Mar 4;14(2):120-123. doi: 10.55729/2000-9666.1303. eCollection 2024.
7
Meeting the Therapeutic Challenges of Emergent and Rare Invasive Fungal Diseases Through Novel Clinical Trial Designs.
Open Forum Infect Dis. 2024 Jun 17;11(6):ofae257. doi: 10.1093/ofid/ofae257. eCollection 2024 Jun.
10
Emergence of highly resistant in the United Arab Emirates: a retrospective analysis of evolving national trends.
Front Public Health. 2024 Jan 12;11:1244358. doi: 10.3389/fpubh.2023.1244358. eCollection 2023.

本文引用的文献

2
Nosocomial fungemia by Candida auris: First four reported cases in continental Europe.
Rev Iberoam Micol. 2017 Jan-Mar;34(1):23-27. doi: 10.1016/j.riam.2016.11.002. Epub 2017 Jan 25.
3
Biofilm-Forming Capability of Highly Virulent, Multidrug-Resistant Candida auris.
Emerg Infect Dis. 2017 Feb;23(2):328-331. doi: 10.3201/eid2302.161320.
4
Multidrug-Resistant Candida haemulonii and C. auris, Tel Aviv, Israel.
Emerg Infect Dis. 2017 Feb;23(1):195-203. doi: 10.3201/eid2302.161486.
6
Invasive Infections with Multidrug-Resistant Yeast Candida auris, Colombia.
Emerg Infect Dis. 2017 Jan;23(1):162-164. doi: 10.3201/eid2301.161497.
8
Hospital transmitted Candida auris infections confirmed in the US.
BMJ. 2016 Nov 7;355:i5978. doi: 10.1136/bmj.i5978.
9
First hospital outbreak of the globally emerging in a European hospital.
Antimicrob Resist Infect Control. 2016 Oct 19;5:35. doi: 10.1186/s13756-016-0132-5. eCollection 2016.
10
Whole genome sequencing of emerging multidrug resistant Candida auris isolates in India demonstrates low genetic variation.
New Microbes New Infect. 2016 Jul 29;13:77-82. doi: 10.1016/j.nmni.2016.07.003. eCollection 2016 Sep.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验